Clinical trial Recruiting at 1 site Interventional Ages 12 to 25

Helping young cancer survivors manage stress and build resilience

Official title: Promoting Resilience in Early Survivorship Among Adolescents and Young Adults With Cancer

Run by Dana-Farber Cancer Institute · NCT06038318 · Data updated 2026-11-12

This study is testing a program that helps young cancer survivors manage stress and build resilience through coaching and education delivered via a mobile app or video.

More Anxiety trials

Quick facts

Study typeInterventional
Ages12 Years to 25 Years
SexAll
Enrollment325 (estimated)
SponsorDana-Farber Cancer Institute
Academic / other
Locations2 sites (Boston, Massachusetts and 1 other locations)
StatusRecruiting
StartedOctober 16, 2023
Main results expectedDecember 31, 2026
Study endsMay 1, 2027
Registry record updatedDecember 29, 2025
Trial IDNCT06038318 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adolescents and young adults aged 12 to 25 who have completed their main cancer-directed therapy.

Probably not a fit

Patients who are not fluent in English or Spanish, or those who are unable to participate cognitively, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to identify effective methods for assisting adolescents and young adults in managing the stress associated with cancer survivorship. Participants will engage in the PRISM program, which includes six sessions of resilience education delivered through a mobile app, text, or video coaching. The study employs a randomized design where participants may be assigned to different intervention methods to evaluate their effectiveness. The research will last up to six months and involves screening and questionnaires to assess participant eligibility and progress.

Why it matters

Potential benefit: If successful, this program could significantly enhance the ability of young cancer survivors to cope with stress and improve their overall mental health.

How similar studies have gone: Previous studies have shown promise in using mobile and digital interventions for stress management in similar populations, indicating a potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Participants that have completed their main cancer-directed therapy at one of the study sites affiliated centers who meet all the eligibility criteria will be eligible for participation in this study.

Inclusion Criteria:

* All genders ≥ 12 and ≤ 25 years of age at baseline
* Participant is able to speak English or Spanish language (for PRISM sessions)
* Participant is able to read English or Spanish language (for completion of surveys)
* Participant is cognitively able to participate in PRISM sessions and complete written questionnaires and surveys, as judged by the site investigator

Where it's running

  • Dana-Farber Cancer Institute
    Boston, Massachusetts, United States
    Recruiting
  • Boston Children's Hospital
    Boston, Massachusetts, United States
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.